검색어 : 통합검색[Janssens Peter]
총 836건 중 836건 출력
, 84/84 페이지
-
831
- Exercise for the Prevention of Anthracycline-Induced Functional Disability and Cardiac Dysfunction: The BREXIT Study
- Foulkes, Stephen J.; Howden, Erin J.; Haykowsky, Mark J.; Antill, Yoland; Salim, Agus; Nightingale, Sophie S.; Loi, Sherene; Claus, Piet; Janssens, Kristel; Mitchell, Amy M.; Wright, Leah; Costello, Ben T.; Lindqvist, Anniina; Burnham, Lauren; Wallace, Imogen; Daly, Robin M.; Fraser, Steve F.; La Gerche, André Sports Cardiology (S.J.F., K.J., A.M.M., L.W., B.T.C., A.L., L.B., I.W., A.L.G.), Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.; Human Integrative Physiology (E.J.H., L.B., I.W.), Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.; Faculty of Nursing, College of Health Sciences, University of Alberta, Edmonton, Canada (M.J.H., S.J.F.).; Cabrini Health, Melbourne, VIC, Australia (Y.A.).; Epidemiology (A.S.), Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (S.S.N., S.L.).; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (S.S.N., S.L.).; Department of Cardiovascular Sciences, KU Leuven, Belgium (P.C.).; Sports Cardiology (S.J.F., K.J., A.M.M., L.W., B.T.C., A.L., L.B., I.W., A.L.G.), Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.; Sports Cardiology (S.J.F., K.J., A.M.M., L.W., B.T.C., A.L., L.B., I.W., A.L.G.), Baker Heart and Diabetes Institute, Melbourn; (Circulation, v.147, 2023, pp.532-545)
-
832
- P644Changes in cardiopulmonary fitness and cardiac reserve 12-months following anthracycline-based chemotherapy with or without concurrent exercise training
- Foulkes, S; Foulkes, S J; Fraser, S; Howden, E J; Bigran, A; Selig, S; Daly, R; Janssens, K; Antill, Y; Loi, S; La Gerche, A; Baker IDI Heart and Diabetes Institute, Sports Cardiology, Melbourne, Australia; Deakin University, Institute of Physical Activity and Nutrition, Melbourne, Australia; Deakin University, Institute of Physical Activity and Nutrition, Melbourne, Australia; Baker IDI Heart and Diabetes Institute, Sports Cardiology, Melbourne, Australia; Baker IDI Heart and Diabetes Institute, Sports Cardiology, Melbourne, Australia; Deakin University, Institute of Physical Activity and Nutrition, Melbourne, Australia; Deakin University, Institute of Physical Activity and Nutrition, Melbourne, Australia; Baker IDI Heart and Diabetes Institute, Sports Cardiology, Melbourne, Australia; Cabrini Hospital, Medical Oncology, Melbourne, Australia; Peter MacCallum Cancer Centre, Melbourne, Australia; Baker IDI Heart and Diabetes Institute, Sports Cardiology, Melbourne, Australia; (European heart journal, v.39, 2018, )
-
833
- Traditional markers of cardiac toxicity fail to detect marked reductions in cardiorespiratory fitness among cancer patients undergoing anti-cancer treatment
- Howden, Erin J; Foulkes, Steve; Dillon, Hayley T; Bigaran, Ashley; Wright, Leah; Janssens, Kristel; Comie, Prue; Costello, Benedict; La Gerche, André Sports Cardiology Lab, Baker Heart and Diabetes Institute, 75 Commercial Rd, Melbourne, VIC 3004, Australia; Sports Cardiology Lab, Baker Heart and Diabetes Institute, 75 Commercial Rd, Melbourne, VIC 3004, Australia; Sports Cardiology Lab, Baker Heart and Diabetes Institute, 75 Commercial Rd, Melbourne, VIC 3004, Australia; Sports Cardiology Lab, Baker Heart and Diabetes Institute, 75 Commercial Rd, Melbourne, VIC 3004, Australia; Sports Cardiology Lab, Baker Heart and Diabetes Institute, 75 Commercial Rd, Melbourne, VIC 3004, Australia; Sports Cardiology Lab, Baker Heart and Diabetes Institute, 75 Commercial Rd, Melbourne, VIC 3004, Australia; Peter MaCallum Cancer Centre, Melbourne, VIC, Australia; Sports Cardiology Lab, Baker Heart and Diabetes Institute, 75 Commercial Rd, Melbourne, VIC 3004, Australia; Sports Cardiology Lab, Baker Heart and Diabetes Institute, 75 Commercial Rd, Melbourne, VIC 3004, Australia; (European heart journal cardiovascular Imaging, v.22, 2021, pp.451-458)
-
834
- O-0017 PREOPERATIVE CHEMORADIOTHERAPY AND POSTOPERATIVE CHEMOTHERAPY WITH CAPECITABINE AND OXALIPLATIN VS. CAPECITABINE ALONE IN LOCALLY ADVANCED RECTAL CANCER: DISEASE FREE SURVIVAL AT INTERIM ANALYSIS
- Schmoll, H.J.; Haustermans, K.; Price, T.; Nordlinger, B.; Hofheinz, R.; Daisne, J.F.; Janssens, J.; Brenner, B.; Schmidt, P.; Reinel, H.; Hollerbach, S.; Caca, K.; Fauth, F.; Hannig, C.V.; Zalcberg, J.; Tebbutt, N.; Mauer, M.; Messina, C.; Lutz, M.; Van Cutsem, E.; Martin Luther University Halle-Wittenberg, Halle, Germany; University Hospitals Leuven, Leuven, Belgium; Queen Elizabeth Hospital and University of Adelaide, Woodville, Australia; Centre Hospitalier Universitaire Ambroise Paré , Assistance Publique Hô pitaux de Paris, Boulogne-Billancourt, France; Universitaetsmedizin Mannheim, Mannheim, Germany; Clinique et Maternité Sainte Elisabeth, Namur, Belgium; AZ Turnhout, Turnhout, Belgium; Rabin Medical Center - Tel Aviv University, Petah Tiqva, Israel; Staedt. Klinikum Neunkirchen, Neunkirchen, Germany; Leopoldina-Krankenhaus der Stadt Schweinfurt GGMBH, Schweinfurt, Germany; Allgemeines Krankenhaus Celle, Celle, Germany; Klinikum Ludwigsburg, Ludwigsburg, Germany; Onkologische Schwerpunktpraxis, Hanau, Germany; Gemeinschaftspraxis Haematologie und Onkologie, Bottrop, Germany; Peter MacCallum Cancer Centre, Melbourne, Australia; Austin-Health, Heidelberg, Australia; EORTC Data Center, Brussels, Belgiu; (Annals of oncology : official journal of the European Society for Medical Oncology, v.25, 2014, pp.ii111-ii112)
-
835
- IMMUNOCHEMOTHERAPY WITH OBINUTUZUMAB OR RITUXIMAB IN a SUBSET OF PATIENTS IN THE RANDOMISED GALLIUM TRIAL WITH PREVIOUSLY UNTREATED MARGINAL ZONE LYMPHOMA (MZL)
- Herold, M.; Hoster, E.; Janssens, A.; McCarthy, H.; Tedeschi, A.; Pocock, C.; Rosta, A.; Schmidt, P.; Trně ný , M.; Burciu, A.; Fingerle‐ Rowson, G.; Rufibach, K.; Zeuner, H.; Hiddemann, W.; Marcus, R.; Oncology Center, HELIOS‐ Klinikum Erfurt, Erfurt, Germany; Department of Medicine III, Ludwig‐ Maximilians‐ University Hospital Munich, Munich, Germany; Department of Haematology, UZ Leuven, Leuven, Belgium; Department of Haematology, Royal Bournemouth General Hospital, Bournemouth, UK; Division of Hematology, A. O. Ospedale Niguarda Ca’ Granda, Milan, Italy; Department of Haematology, Kent & Canterbury Hospital, Canterbury, UK; Department of Haematology, Orszá gos Onkoló giai Inté zet, Budapest, Hungary; Dr. med. Peter Schmidt, Praxis, Neunkirchen/Saar, Germany; 1st Department of Medicine, Charles University General Hospital, Prague, Czech; (Hematological oncology, v.35, 2017, pp.146-147)
-
836
- O-0023 PREOPERATIVE CHEMORADIOTHERAPY AND POSTOPERATIVE CHEMOTHERAPY WITH CAPECITABINE AND OXALIPLATIN VS. CAPECITABINE ALONE IN LOCALLY ADVANCED RECTAL CANCER: RESPONSE TO THE LOCAL TREATMENT AFTER CHEMORADIATION AND SURGERY AS SECONDARY ENDPOINT
- Schmoll, Hans-Joachim; Haustermans, Karin; Price, Timothy; Nordlinger, Bernard; Hofheinz, Ralf; Daisne, J-F; Janssens, J; Brenner, B.; Schmidt, P; Reinel, H.; Hollerbach, S.; Caca, K.; Fauth, F.; Hannig, C.V.; Zalcberg, John; Tebbutt, Niall; Mauer, Murielle; Messina, C.; Lutz, Manfred; Van Cutsem, Eric; Martin Luther University Halle-Wittenberg, Halle, Germany; U.Z. Leuven - Campus Gasthuisberg, Leuven, Belgium; Queen Elizabeth Hospital and University of Adelaide, Woodville South, Australia; Centre Hospitalier Universitaire Ambroise Paré , Assistance Publique Hô pitaux de Paris, Boulogne-Billancourt, France; Universitaetsmedizin Mannheim, Mannheim, Germany; Clinique et Maternité Sainte Elisabeth, Namur, Belgium; AZ Turnhout, Turnhout, Belgium; Rabin Medical Center - Tel Aviv University, Petah Tiqva, Israel; Staedt. Klinikum Neunkirchen, Neunkirchen, Germany; Leopoldina-Krankenhaus der Stadt Schweinfurt GGMBH, Schweinfurt, Germany; Allgemeines Krankenhaus Celle, Celle, Germany; Klinikum Ludwigsburg, Ludwigsburg, Germany; Onkologische Schwerpunktpraxis, Hanau, Germany; Gemeinschaftspraxis Haematologie und Onkologie, Bottrop, Germany; Peter MacCallum Cancer Centre, Melbourne, Australia; Austin-Health, Heidelberg, Australia; EORTC Data Cente; (Annals of oncology : official journal of the European Society for Medical Oncology, v.24, 2013, pp.iv120-iv120)
QUICK MENU
